Orion Portfolio Solutions LLC cut its stake in shares of Balchem Co. (NASDAQ:BCPC – Free Report) by 13.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,841 shares of the basic materials company’s stock after selling 425 shares during the period. Orion Portfolio Solutions LLC’s holdings in Balchem were worth $463,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Arizona State Retirement System boosted its holdings in Balchem by 0.8% in the fourth quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company’s stock valued at $1,534,000 after acquiring an additional 77 shares during the last quarter. Heritage Family Offices LLP lifted its stake in shares of Balchem by 8.3% in the 4th quarter. Heritage Family Offices LLP now owns 1,420 shares of the basic materials company’s stock valued at $231,000 after purchasing an additional 109 shares in the last quarter. Inspire Investing LLC grew its holdings in shares of Balchem by 4.9% during the 4th quarter. Inspire Investing LLC now owns 2,462 shares of the basic materials company’s stock worth $401,000 after purchasing an additional 114 shares during the period. Westside Investment Management Inc. acquired a new stake in Balchem during the 3rd quarter worth approximately $27,000. Finally, Inspire Advisors LLC raised its holdings in Balchem by 3.2% in the fourth quarter. Inspire Advisors LLC now owns 5,123 shares of the basic materials company’s stock valued at $835,000 after buying an additional 161 shares during the period. 87.91% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
BCPC has been the subject of several research reports. HC Wainwright reiterated a “buy” rating and set a $190.00 price objective on shares of Balchem in a research note on Monday, February 24th. StockNews.com cut shares of Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. Finally, Sidoti raised Balchem to a “hold” rating in a research report on Tuesday, February 25th.
Balchem Stock Down 1.1 %
NASDAQ BCPC opened at $154.13 on Tuesday. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. Balchem Co. has a fifty-two week low of $137.69 and a fifty-two week high of $186.03. The business has a 50 day moving average price of $165.30 and a two-hundred day moving average price of $168.79. The stock has a market cap of $5.01 billion, a PE ratio of 39.22, a P/E/G ratio of 4.41 and a beta of 0.75.
Balchem (NASDAQ:BCPC – Get Free Report) last announced its earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing the consensus estimate of $1.11 by ($0.08). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The firm had revenue of $240.00 million during the quarter, compared to analysts’ expectations of $239.96 million. As a group, sell-side analysts predict that Balchem Co. will post 4.64 EPS for the current fiscal year.
Balchem Company Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Featured Stories
- Five stocks we like better than Balchem
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Options Activity Points to More Volatility for Palantir Stock
- Insider Selling Explained: Can it Inform Your Investing Choices?
- NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?
- Canada Bond Market Holiday: How to Invest and Trade
- MicroStrategy Sees Insider Buy-Sell Action in Q1
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.